Urology Laser Market Size & Outlook, 2026-2034

Urology Laser Market Overview

The global urology laser market size is valued at USD 1.20 billion in 2025 and is estimated to reach USD 2.10 billion by 2034, growing at a CAGR of 6% during the forecast period. The market is primarily driven by factors such as an increase in the number of patients suffering from urology-related disorders and a rising preference for minimally invasive surgeries.

Key Trends and Highlights

• North America dominated the global urology laser market, accounting for the largest revenue share of over 37% in 2025.
• Asia Pacific is expected to exhibit the fastest growth rate of 7.4% during the forecast period.
• Based on type, the holmium laser system segment dominated the market, accounting for a 35% revenue share in 2025.
• Based on application, the stone removal/urolithiasis segment is the fastest-growing application,exhibiting a CAGR of 6.7%.
• By End-User, Hospitals remain the largest end-user segment, holding a revenue share of 41.5%.
• The U.S. dominates the North America urology laser industry with largest revenue share.

Market Revenue Figures

• 2025 Market Size: USD 1.20 billion
• 2034 Projected Market Size: USD 2.10 billion
• CAGR (2026-2034): 6%
• Dominating Region: North America
• Fastest-Growing Region: Asia Pacific

The global urology laser market is expanding due to the rising prevalence of urologic disorders and growing preference for non-invasive procedures. Increasing product approvals, R&D activity, and the adoption of laser-based treatments for kidney stones, BPH, and soft-tissue conditions further support market growth. Ongoing advancements in fibre-laser technologies, improved energy-delivery systems, and strategic initiatives from emerging players offer significant growth opportunities. These innovations enhance precision, reduce complications, and improve workflow efficiency, driving the continued shift toward laser-enabled urology treatments.

Latest Market Trends

Shift toward minimally invasive procedures

The market is experiencing a significant shift toward minimally invasive urological treatments, driven by faster recovery times, reduced hospital stays, lower complication rates, and improved patient comfort. Laser procedures for kidney stones, BPH, and soft-tissue conditions are increasingly preferred because they offer precise tissue targeting, minimal bleeding, and shorter operative times versus traditional surgery. Healthcare systems are also transitioning more cases to outpatient and ambulatory surgical centres, where laser technologies support efficient workflows and same-day discharge. The growing demand for safer, quicker, and cost-effective procedures continues to accelerate the adoption of minimally invasive laser-based urology treatments across global healthcare settings.

Evolution from Classic to Advanced Laser Systems

Urology laser technology is rapidly advancing from conventional Holmium: YAG systems to next-generation fibre-laser and pulse-modulated platforms. Thulium fibre lasers are gaining strong traction due to their superior stone dusting capabilities, minimal retropulsion, enhanced hemostasis, and reduced thermal damage, thereby improving safety and procedure efficiency. Pulse-modulated Holmium systems, such as MOSES-like technologies, further optimise energy delivery for better stone fragmentation and smoother tissue interaction. These enhanced systems provide surgeons with greater precision, versatility, and workflow efficiency across a broader range of urological procedures. As technology becomes smarter and more advanced, its clinical adoption continues to rise globally.

To get more insights about this report Download Free Sample Report

Market Driver

Rising Research and Development Activities for Urology Laser Devices

Increasing R&D investment is a major driver for the urology laser market, enabling the development of innovative devices that address unmet clinical needs. Research focuses on refining laser technologies for conditions such as BPH, bladder tumours, urolithiasis, urinary strictures, and genital lesions. Advancements in laser efficiency, safety, and multifunctionality expand treatment options and improve patient outcomes. Market players are investing in new platforms, aiming to reduce procedure times, enhance stone fragmentation, and improve tissue ablation. Strong clinical demand for minimally invasive therapies continues to encourage collaboration between researchers and manufacturers, driving innovation and accelerating market growth.

Market Restraint

High Cost of Urology Laser Device and Procedure

The high cost of urology laser devices and related procedures remains a major barrier to market growth. These systems require expensive manufacturing, ongoing maintenance, and trained specialists, increasing overall treatment costs. Limited insurance coverage and high out-of-pocket expenses discourage adoption, especially in low- and middle-income regions. Cost constraints often prevent smaller hospitals and clinics from investing in advanced laser platforms. Despite their clinical benefits, the financial burden slows market penetration. However, as technology evolves and production becomes more cost-efficient, prices may gradually decrease, improving accessibility and supporting wider adoption across global healthcare systems.

Market Opportunity

Technological Advancements in Laser Technology

Technological advancements in laser systems present significant opportunities for market growth. Modern urology lasers offer enhanced precision, lower thermal injury, efficient stone dusting, and improved soft-tissue ablation, supporting faster recovery and reduced surgical complications. These innovations are increasingly used to treat conditions such as prostatic hyperplasia, bladder tumours, and kidney stones. Automation features and improved energy-delivery systems also reduce reliance on manual tools, streamline workflows, and shorten treatment times. As hospitals seek more efficient and minimally invasive solutions, next-generation laser devices are expected to replace traditional surgical instruments, expanding the role of laser technology in urology care.

Regional Analysis

North America led the urology laser market with a 37% revenue share in 2025, driven by high cases of urolithiasis, BPH, and bladder tumours. According to NCBI, nearly 50% of U.S. patients develop urinary stones linked to calcium intake and hydration patterns, boosting demand for laser lithotripsy. Strong technological adoption, including systems like Lumenis MOSES for advanced holmium lithotripsy and BPH procedures, further strengthens market growth. Well-established healthcare infrastructure, skilled urologists, and favourable reimbursement environments ensure rapid integration of next-generation laser platforms across both hospitals and ambulatory surgical centres.

• The U.S. dominates the regional market due to its advanced healthcare ecosystem, high adoption of minimally invasive urology technologies, and strong reimbursement pathways for laser-based procedures. Continuous investment in innovation, strong regulatory support, and increasing patient preference for minimally invasive care keep the U.S. at the forefront of urology laser adoption.

Asia Pacific Market Insights

The Asia Pacific is expected to register the highest CAGR of 7.4% in 2025 over the forecast period, driven by the rising prevalence of urolithiasis and increasing utilisation of laser-based lithotripsy. According to NCBI, around 19% of the region’s population suffers from urinary stones, driven by genetic predisposition, dietary patterns, dehydration, and climatic factors. Rapid development of healthcare infrastructure, the growing availability of skilled practitioners, and expanding access to minimally invasive technologies further support market growth.

• China emerges as the leading Asia Pacific market due to its large patient population, rapid hospital modernisation, and high procedure volumes for BPH and stone-management surgeries. Strong government investment in tertiary care facilities, combined with the widespread adoption of both holmium and thulium fibre lasers, fuels growth. Chinese hospitals are increasingly integrating advanced systems to enhance surgical precision, minimise complications, and expand minimally invasive urology services.

Europe Market Insights

Europe is among the most mature and technologically advanced markets. Strong healthcare infrastructure, early adoption of minimally invasive laser procedures, and broad availability of holmium and thulium fiber lasers drive growth. The region benefits from favourable reimbursement, high surgeon expertise, and an increasing focus on outpatient procedures. Germany leads with a strong purchasing capacity, a high prevalence of BPH and stones in its ageing population, and streamlined reimbursement for advanced laser systems.

• Germany maintains regional leadership due to widespread adoption of minimally invasive urology procedures, strong investment in advanced surgical technologies, and well-established reimbursement coverage. Germany’s strong manufacturing base, clinical research capacity, and consistent hospital modernisation programs further accelerate technology adoption, positioning the country as a benchmark for advanced urology laser utilisation across Europe.

Latin America Market Insights

Latin America is a steadily expanding market, driven by rising kidney stone and BPH prevalence, improving healthcare access, and the gradual modernisation of hospital infrastructure. Holmium lasers dominate installations, while thulium systems are gaining traction as facilities adopt advanced, minimally invasive technologies. Growth is supported by demographic ageing, increasing awareness of laser-based procedures, and higher investments from private urology centres. Although disparities in healthcare access exist, major urban centres are accelerating the adoption of healthcare services, positioning Latin America as an emerging opportunity for global manufacturers seeking regional expansion.

• Brazil is the largest and most advanced urology laser market in Latin America, driven by high prevalence of kidney stones and BPH, strong adoption of minimally invasive surgical technologies, and rapid expansion of private healthcare. Brazilian hospitals exhibit higher installation rates of holmium and thulium laser systems compared to neighbouring countries, which is attributed to better funding, increased specialist availability, and a growing demand for efficient outpatient procedures.

The Middle East and Africa Market Insights

The Middle East and Africa market is steadily growing due to improving healthcare infrastructure, rising awareness of minimally invasive therapies, and increasing prevalence of kidney stones and BPH. Holmium lasers currently dominate adoption, while advanced fibre-laser systems are gradually entering tertiary hospitals and speciality clinics. Growth is strongest in urban centres, where private healthcare investment is expanding. Despite disparities across countries, rising diagnostic capabilities, medical tourism, and government-backed modernisation programs position MEA as a promising emerging market for urology laser technologies.

• Saudi Arabia leads the MEA market with advanced healthcare infrastructure, early adoption of minimally invasive urology technologies, and high prevalence of urinary stones and BPH. Well-funded public and private hospitals consistently procure holmium and thulium systems, supported by favourable reimbursement and strong availability of trained urologists. The country’s focus on technological modernisation, investment in specialised urology centres, and expansion of medical tourism boosts procedural volume.

Laser Type Insights

The holmium laser system dominated the market with a 35% revenue share in 2025, due to its proven safety, precision, and effectiveness in minimally invasive procedures for prostate and stone management. Its ability to remove obstructive prostate tissue without incisions, along with shorter recovery times and same-day discharge, drives continued adoption. The procedure typically lasts 45–90 minutes and offers reduced bleeding and complications, making holmium lasers a preferred choice among urologists. These clinical and operational benefits strengthen their long-term market demand.

Thulium lasers are expected to grow at the highest CAGR of 5.7% due to clear advantages over traditional TURP procedures. They offer precise tissue cutting, reduced bleeding, and faster recovery, making them highly effective for BPH treatment with minimal postoperative complications. Their ability to deliver controlled energy with fewer incisions enhances safety and patient comfort.

Application Insights

Benign Prostatic Hyperplasia remains the largest application segment, accounting for 45.7% of market share during the forecast period. Its dominance stems from the rising incidence of prostate enlargement in ageing male populations and the shift toward minimally invasive laser therapies. The growing clinical preference for laser enucleation and vaporisation procedures continues to drive demand across hospitals, outpatient centres, and specialised urology facilities worldwide.

The stone removal/urolithiasis segment is the fastest-growing application, exhibiting a CAGR of 6.7% due to rising global prevalence of urinary stones and increasing adoption of laser lithotripsy as the preferred minimally invasive treatment. Their high procedural success rates and compatibility with modern fibre and pulse-modulated technologies drive adoption in both hospital and outpatient settings, making stone lithotripsy a key driver of growth for the urology laser market.

End-User Insights

Hospitals remain the largest end-user segment, holding a revenue share of 41.5% due to their advanced surgical infrastructure, availability of trained specialists, and ability to manage complex urology cases. Higher patient volumes and established referral pathways support the adoption of high-cost laser systems. Their strong capital capacity and focus on technology upgrades ensure sustained dominance in the urology laser market.

Ambulatory Surgical Centers represent the fastest-growing segment, expanding at a CAGR of 15%. ASCs are ideal for same-day procedures, such as stone lithotripsy and BPH treatments, due to their shorter recovery times and cost-effective care models. Increasing patient preference for outpatient care, combined with lower procedural costs and streamlined workflows, continues to shift urology surgeries away from hospitals and toward ambulatory settings globally.

Competitive Landscape

The global urology laser market presents a notably competitive landscape, characterised by the presence of well-established leaders vying for market supremacy, while innovative newcomers are determined to establish their unique positions. Distinguished companies like Lumenis Ltd., Boston Scientific Corporation and Olympus Corporation have firmly entrenched themselves as industry stalwarts, offering a comprehensive array of urology laser systems and accompanying accessories.

List of key players in Urology Laser Market

1. Allengers
2. Biolitec AG
3. Boston Scientific Corporation
4. Cook Group
5. En. Group
6. Lumenis
7. Medtronic
8. Olympus Corporation
9. OmniGuide Holdings Inc.
10. Richard Wolf GmbH
11. Surgical Lasers Inc
12. Karl Storz GmbH & Co.Kg
13. Jena Surgical GmbH
14. Starmedtec Gmbh

To get more findings about this report Download Market Share

Recent Developments

• September 2025 - Olympus announced a Distribution Partnership with MacroLux Medical for Single-Use Urology Products.
• July 2025 - Biolitec announced that its new LEONARDO Duster Thulium Fibre Laser (TFL) system received FDA approval. The device is intended for a range of urology applications, including lithotripsy, prostatic hyperplasia, and soft tissue treatment.
• February 2025 - Karl Storz completed the business transfer of medi-G, adding sustainable capacity for complex assemblies used in urology.